Galya Blachman
Algemeen Adviseur bij 501 ACQU
Actieve functies van Galya Blachman
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| 501 ACQU | Algemeen Adviseur | 01-09-2020 | - |
| Bedrijfssecretaris | 01-09-2020 | - | |
| ENLIVEN THERAPEUTICS, INC. | Algemeen Adviseur | 01-04-2020 | - |
| Biotech Connection-Bay Area, Inc. | Algemeen Adviseur | 01-06-2018 | - |
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Algemeen Adviseur | 01-09-2018 | - |
| Compliance Officer | 01-09-2018 | - | |
| Operationeel Directeur | 01-09-2018 | - |
Loopbaan van Galya Blachman
Eerdere bekende functies van Galya Blachman
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Stemcentrx, Inc.
 Stemcentrx, Inc. BiotechnologyHealth Technology Stemcentrx, Inc. develops life-changing therapies for cancer patients. It develops proprietary discovery platforms that yield unprecedented insight into the biology of tumors and are being exploited to develop potent new cancer drugs. The firm specializes in designing drugs to target cancer stem cells, which are the cells that cause cancer to spread throughout the body. The company was founded by Brian Christopher Slingerland, Daniel T. Reiner and Scott J. Dylla in 2008 and is headquartered in San Francisco, CA. | Algemeen Adviseur | 01-07-2012 | 01-01-2017 |
Opleiding van Galya Blachman
| University of Oxford | Graduate Degree |
| University of Cambridge | Doctorate Degree |
| University of Cape Town | Graduate Degree |
| BPP Law School | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
| Verenigd Koninkrijk | 4 |
| Zuid-Afrika | 2 |
Operationeel
| General Counsel | 5 |
| Graduate Degree | 3 |
| Corporate Secretary | 1 |
Sectoraal
| Consumer Services | 5 |
| Finance | 3 |
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ENLIVEN THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
5:01 Acquisition Corp.
 5:01 Acquisition Corp. Financial ConglomeratesFinance 5:01 Acquisition Corp. is a blank check emerging growth company that was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on August 31, 2020 and is headquartered in San Francisco, CA. | Finance |
Stemcentrx, Inc.
Stemcentrx, Inc. BiotechnologyHealth Technology Stemcentrx, Inc. develops life-changing therapies for cancer patients. It develops proprietary discovery platforms that yield unprecedented insight into the biology of tumors and are being exploited to develop potent new cancer drugs. The firm specializes in designing drugs to target cancer stem cells, which are the cells that cause cancer to spread throughout the body. The company was founded by Brian Christopher Slingerland, Daniel T. Reiner and Scott J. Dylla in 2008 and is headquartered in San Francisco, CA. | Health Technology |
| Biotech Connection-Bay Area, Inc. | |
5AM Venture Management LLC
5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Finance |
- Beurs
- Insiders
- Galya Blachman
- Ervaring
